-
EchoLUTION™ Plant DNA Kit Delivers High-Purity Genomic DNA from Challenging Plant Matrices in Under 90 Minutes
Plant DNA extraction is notoriously demanding. Polyphenols, polysaccharides, and pigments co-purify with DNA during extraction, inhibiting downstream enzymatic reactions and reducing sequencing data quality. Silica-based methods frequently require custom buffer adaptations or result in clogged columns when processing plant tissue, and yield can vary significantly across species and tissue types. BioEcho’s EchoLUTION Plant DNA Kit addresses these challenges directly, delivering high-purity genomic DNA from diverse plant matrices in a single-step workflow completable in under 90 minutes. The kit applies BioEcho’s EchoLUTION flow-through purification technology — the same principle used across the company’s broader product range. Rather than binding DNA to a silica membrane and releasing it through sequential wash and…
-
BioEcho’s EchoLUTION FFPE RNA Kit Outperforms Competing Methods in Independent Head-to-Head Evaluation
An independent performance evaluation conducted by TAmiRNA, a specialist in small RNA biomarker research, has ranked BioEcho’s EchoLUTION FFPE RNA Kit as the top-performing solution for RNA isolation from formalin-fixed paraffin-embedded (FFPE) tissue — ahead of both the silica-membrane extraction and magnetic bead-based method. FFPE samples are among the most challenging starting materials in molecular diagnostics. Formalin fixation causes chemical modifications and cross-linking that degrade RNA and make recovery difficult. Despite this, high-quality RNA extraction from archival FFPE tissue is essential for oncology research, biomarker discovery, and clinical pathology workflows. The evaluation compared all three kits across RNA yield, RNA quality, cDNA library quality, and next-generation sequencing (NGS) output. Across…
-
BioEcho Achieves ISO 9001:2015 Recertification, Reinforcing Commitment to Quality and Reliability
BioEcho, an Admera Health company delivering innovative nucleic acid purification and laboratory solutions, proudly announces that it has successfully achieved ISO 9001:2015 recertification. This milestone underscores the company’s ongoing dedication to providing high-quality, reliable, and sustainable products to researchers and laboratory professionals worldwide, while also delivering faster and more effective operations. ISO 9001 is an internationally recognized standard for quality management systems, ensuring that organizations consistently meet customer and regulatory requirements while continually improving processes. BioEcho’s recertification reflects its commitment to maintaining the highest operational standards across all aspects of its business, from product development and manufacturing to customer support. “Quality is at the heart of everything we do at…
-
BioEcho Launches EchoLUTION™: The New Era of Nucleic Acid Purification. Get Pure DNA/RNA in One Single Step, Saving Up to 70% of Time.
For over three decades, nucleic acid purification has relied on solid-phase binding techniques. Silica membrane spin columns, once considered revolutionary, became standard. These systems force nucleic acids to bind to silica under high salt and ethanol concentrations—followed by multiple washing and elution steps. This method is indirect, harsh, and inefficient: not only are valuable nucleic acid fragments lost during binding or washing, but the method is also time-consuming and labor-intensive, requiring numerous high-speed centrifugation steps and consumables. Magnetic beads added automation compatibility but retained the same chemical principles and complexity: bind–wash–elute in slightly more flexible formats. Organic extraction methods (phenol-chloroform) offered high yields at the cost of toxicity, contamination risk,…
-
Neues EchoLUTION™ Zellkultur-RNA-Aufreinigungs-Kit von BioEcho bietet überragende Qualität und Geschwindigkeit für die akademische und biopharmazeutis
BioEcho Life Sciences GmbH, ein Unternehmen von Admera Health, hat sein neues EchoLUTION™ Zellkultur-RNA-Aufreinigungs-Kit für höchste RNA-Qualität auf den Markt gebracht. Dieses Kit basiert auf der revolutionären EchoLUTION™-Technologie, womit hohe Recovery Rates und mehr verwertbare Reads in nachgelagerten Next-Generation-Sequencing Anwendungen erzielt werden. Dieser neue Ansatz stellt die Logik der traditionellen Aufreinigung auf den Kopf, die sich jahrzehntelang auf ineffiziente Bindungstechniken und umweltschädliche Substanzen stützte. Indem Verunreinigungen zurückgehalten und die Nukleinsäuren in einem einzigen Schritt durchgelassen werden, entfallen viele Waschschritte, die eine Hauptursache für Zeitaufwand, Kontaminationen und Probenverluste sind. „Wir sind stolz darauf, ein Produkt vorstellen zu können, das die Effizienz und Qualität von Nukleinsäure-Aufreinigungs-Workflows erheblich verbessern wird“, sagte Dr. Sarah…
-
BioEcho Life Sciences Secures European Patent for EchoLUTION™ Technology.
BioEcho Life Sciences is pleased to broadcast that the European Patent Office has granted a patent for the groundbreaking EchoLUTION technology (Nr. EP3619309). The patent application titled "Rapid purification of high-quality nucleic acids from biological samples" highlights the uniqueness and novelty of the technology. "We are thrilled to receive European patent approval for our EchoLUTION technology," said Thomas Neuman, CEO of BioEcho Life Sciences. "This recognition validates the ingenuity and dedication of our team in developing innovative solutions that empower researchers worldwide. With this patent secured, we look forward to further expanding the reach of EchoLUTION technology and driving impactfl advancements in molecular biology." The EchoLUTION technology, developed by a…
-
BioEcho Life Sciences sichert sich europäisches Patent für EchoLUTION™-Technologie.
BioEcho Life Sciences freut sich, mitteilen zu können, dass das Europäische Patentamt ein Patent für seine EchoLUTION-Technologie erteilt hat (Nr. EP3619309). Die Patentanmeldung mit dem Titel "Rapid purification of high-quality nucleic acids from biological samples" unterstreicht die Einzigartigkeit und Neuartigkeit der Technologie. "Wir freuen uns sehr über die europäische Patenterteilung für unsere EchoLUTION-Technologie", sagte Thomas Neuman, CEO von BioEcho Life Sciences. "Diese Anerkennung bestätigt den Einfallsreichtum und das Engagement unseres Teams bei der Entwicklung innovativer Lösungen, die Forschern auf der ganzen Welt zugutekommen. Mit diesem Patent freuen wir uns darauf, die Reichweite der EchoLUTION-Technologie weiter auszubauen und bedeutende Fortschritte in der Molekulabiologie zu unterstützen." Die von einem Expertenteam entwickelte EchoLUTION-Technologie…
-
BioEcho Life Sciences introduces the EchoLUTION™ Tissue RNA Kit for fast and reliable RNA extraction without phenol/chloroform
BioEcho Life Sciences, the biotechnology company supplying fast and sustainable nucleic acid extraction technologies, has launched its latest product: the EchoLUTION Tissue RNA Kit — designed to streamline and optimize total RNA extraction from mammalian tissues, including challenging tissues such as muscle. "We are thrilled to introduce the EchoLUTION Tissue RNA Kit," said Christiane Schlottbom, Director Marketing at BioEcho Life Sciences. "This innovative solution represents a significant advancement in RNA extraction technology, offering researchers unparalleled speed, efficiency, and reliability in their experiments. We believe that the EchoLUTION Tissue RNA Kit will greatly simplify the workflow of scientists working in diverse fields of molecular biology, as it provides high-quality RNA without…
-
BioEcho Life Sciences stellt das EchoLUTION™ Tissue RNA Kit für schnelle und zuverlässige RNA-Extraktion ohne Phenol/Chloroform vor
BioEcho Life Sciences, das Biotechnologieunternehmen, das schnelle und nachhaltige Technologien für die Nukleinsäureextraktion anbietet, hat sein neuestes Produkt auf den Markt gebracht: das EchoLUTION Tissue RNA Kit – entwickelt für optimierte Gesamt-RNA-Extraktion aus Säugetiergewebe, einschließlich schwieriger Gewebe wie Muskeln. "Wir freuen uns sehr, das EchoLUTION Tissue RNA Kit vorstellen zu können", sagte Christiane Schlottbom, Director Marketing bei BioEcho Life Sciences. "Diese innovative Lösung stellt einen bedeutenden Fortschritt in der RNA-Extraktionstechnologie dar und bietet Forschern eine unvergleichliche Geschwindigkeit, Effizienz und Zuverlässigkeit bei ihren Experimenten. Wir sind davon überzeugt, dass das EchoLUTION Tissue RNA Kit die Arbeitsabläufe von Wissenschaftlern, die in verschiedenen Bereichen der Molekularbiologie arbeiten, erheblich vereinfachen wird, da es qualitativ…
-
BioEcho Life Sciences announces FDA listing of its EchoLUTION Viral RNA/DNA Kit for nucleic acid extraction
Rapid and accurate clinical diagnostic tests are essential for the detection of viral infections and proper medical care. The EchoLUTION Viral RNA/DNA Kit is specifically designed for the extraction of viral nucleic acids from a variety of samples: It is particularly useful for the detection of respiratory viruses, as well as enteropathogenic viruses contained in stool samples. The kit is IVDR-compliant, CE-marked, and FDA-listed, making it an ideal solution for diagnostic laboratory routines that require high-quality standards. With a more sustainable composition it delivers the same performance as the previously available EchoLUTION Viral RNA/DNA Swab Kit Plus. This predecessor kit has been extensively used in Europe for rapid PCR diagnostics…
